Claudin-11, a key transmembrane protein maintaining BBB and BSCB integrity, is significantly downregulated in both MS patient tissue and EAE models, further linking barrier disruption to disease progression [142]. The gene discussed is CLDN11; the disease is myeloid sarcoma.